ID

12028

Description

Functional MR-guided Stereotactic Body Radiation Therapy of Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01976962 Principal Investigator: Harvey Quon, MD CancerCare Manitoba

Link

https://clinicaltrials.gov/show/NCT01976962

Keywords

Versions (1)
  1. 9/1/15 9/1/15 -
Uploaded on

September 1, 2015

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Prostatic Neoplasms NCT01976962

English

Eligibility Prostatic Neoplasms NCT01976962

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI-1
C1512693
Informed consent
Description

Informed consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
Age >18 years
Description

Age >18 years

Data type

boolean

Alias
UMLS CUI [1]
C0001779
Histologically confirmed and centrally reviewed prostate adenocarcinoma based
Description

Histologically confirmed and centrally reviewed prostate adenocarcinoma based

Data type

boolean

Alias
UMLS CUI [1]
C0007112
PSA within 60 days
Description

PSA within 60 days

Data type

boolean

Alias
UMLS CUI [1]
C0138741
High risk prostate cancer defined as any one of: clinical stage >= T3, Gleason score >= 8, or PSA >=20 and <50 ng/mL.
Description

High risk prostate cancer defined as any one of: clinical stage >= T3, Gleason score >= 8, or PSA >=20 and <50 ng/mL.

Data type

boolean

Alias
UMLS CUI [1]
C0332167
UMLS CUI [2]
C0600139
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI-1
C0680251
Evidence of lymph node metastasis
Description

Evidence of lymph node metastasis

Data type

boolean

Alias
UMLS CUI [1]
C0024204
UMLS CUI [2]
C0027627
Evidence of distant metastases
Description

Evidence of distant metastases

Data type

boolean

Alias
UMLS CUI [1]
C0027627
UMLS CUI [2]
C0443203
Prior pelvic radiotherapy or brachytherapy
Description

Prior pelvic radiotherapy or brachytherapy

Data type

boolean

Alias
UMLS CUI [1]
C0436276
Previous radical prostatectomy, cryotherapy, or high-frequency ultrasound
Description

Previous radical prostatectomy, cryotherapy, or high-frequency ultrasound

Data type

boolean

Alias
UMLS CUI [1]
C0033573
Unable to undergo gold seed insertion
Description

Unable to undergo gold seed insertion

Data type

boolean

Alias
UMLS CUI [1]
C1960738
Immunosuppressive medications
Description

Immunosuppressive medications

Data type

boolean

Alias
UMLS CUI [1]
C0021081
Inflammatory bowel disease
Description

Inflammatory bowel disease

Data type

boolean

Alias
UMLS CUI [1]
C0021390
Unable to undergo MRI
Description

Unable to undergo MRI

Data type

boolean

Alias
UMLS CUI [1]
C0024485
Previous bilateral orchiectomy
Description

Previous bilateral orchiectomy

Data type

boolean

Alias
UMLS CUI [1]
C0029189
UMLS CUI [2]
C0238767
Previous hormonal therapy including LHRH agonists (leuprolide, goserelin), LHRH antagonists (degarelix), anti-androgens (bicalutamide, flutamide, nilutamide), surgical castration, and estrogens
Description

Previous hormonal therapy including LHRH agonists (leuprolide, goserelin), LHRH antagonists (degarelix), anti-androgens (bicalutamide, flutamide, nilutamide), surgical castration, and estrogens

Data type

boolean

Alias
UMLS CUI [1]
C0279025
Previous finasteride within 14 days.
Description

Previous finasteride within 14 days.

Data type

boolean

Alias
UMLS CUI [1]
C0060389
Previous dutasteride within 180 days.
Description

Previous dutasteride within 180 days.

Data type

boolean

Alias
UMLS CUI [1]
C0754659
Back to the top of the page

Similar models

Eligibility Prostatic Neoplasms NCT01976962

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Inclusion Criteria
C1512693 (UMLS CUI-1)
informed consent
Item
Informed consent
boolean
C0021430 (UMLS CUI [1])
age
Item
Age >18 years
boolean
C0001779 (UMLS CUI [1])
prostate adenocarcinoma
Item
Histologically confirmed and centrally reviewed prostate adenocarcinoma based
boolean
C0007112 (UMLS CUI [1])
psa
Item
PSA within 60 days
boolean
C0138741 (UMLS CUI [1])
high risk; Prostate carcinoma
Item
High risk prostate cancer defined as any one of: clinical stage >= T3, Gleason score >= 8, or PSA >=20 and <50 ng/mL.
boolean
C0332167 (UMLS CUI [1])
C0600139 (UMLS CUI [2])
Item Group
Exclusion Criteria
C0680251 (UMLS CUI-1)
lymph nodes; metastasis
Item
Evidence of lymph node metastasis
boolean
C0024204 (UMLS CUI [1])
C0027627 (UMLS CUI [2])
metastases; distant
Item
Evidence of distant metastases
boolean
C0027627 (UMLS CUI [1])
C0443203 (UMLS CUI [2])
pelvic radiotherapy
Item
Prior pelvic radiotherapy or brachytherapy
boolean
C0436276 (UMLS CUI [1])
prostatectomy
Item
Previous radical prostatectomy, cryotherapy, or high-frequency ultrasound
boolean
C0033573 (UMLS CUI [1])
Implantation of radioactive seed into prostate
Item
Unable to undergo gold seed insertion
boolean
C1960738 (UMLS CUI [1])
Immunosuppressive Agents
Item
Immunosuppressive medications
boolean
C0021081 (UMLS CUI [1])
Inflammatory bowel disease
Item
Inflammatory bowel disease
boolean
C0021390 (UMLS CUI [1])
mri
Item
Unable to undergo MRI
boolean
C0024485 (UMLS CUI [1])
orchiectomy; bilateral
Item
Previous bilateral orchiectomy
boolean
C0029189 (UMLS CUI [1])
C0238767 (UMLS CUI [2])
hormonal therapy
Item
Previous hormonal therapy including LHRH agonists (leuprolide, goserelin), LHRH antagonists (degarelix), anti-androgens (bicalutamide, flutamide, nilutamide), surgical castration, and estrogens
boolean
C0279025 (UMLS CUI [1])
finasteride
Item
Previous finasteride within 14 days.
boolean
C0060389 (UMLS CUI [1])
dutasteride
Item
Previous dutasteride within 180 days.
boolean
C0754659 (UMLS CUI [1])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial